Water-Soluble Cannabinoid and/or Terpene Extracts for Diverse Therapeutic Applications

Publication ID: 24-11857589_0002_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Water-Soluble Cannabinoid and/or Terpene Extracts for Diverse Therapeutic Applications,” Published Technical Disclosure No. 24-11857589_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857589_0002_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,589.

Summary of the Inventive Concept

This inventive concept leverages the core technology of water-soluble, powdered cannabinoid and/or terpene extracts to address various unmet medical needs across multiple industries, including dermatology, veterinary care, sleep disorders, gut health, and women's health.

Background and Problem Solved

The original patent disclosed a novel method for creating water-soluble, powdered cannabinoid and/or terpene extracts. However, the patent's scope was limited to specific applications. This inventive concept addresses the need for expanding the technology's reach to tackle diverse therapeutic challenges, such as skin conditions, anxiety in pets, sleep quality, gut inflammation, and menstrual cramps.

Detailed Description of the Inventive Concept

The inventive concept involves the application of water-soluble, powdered cannabinoid and/or terpene extracts to various industries, including dermatology, veterinary care, sleep disorders, gut health, and women's health. The extracts are complexed with a cyclodextrin and emulsified with a combination of maltodextrin and acacia, enabling their use in diverse formulations, such as topical creams, treats, capsules, tablets, and transdermal patches. These formulations can provide relief from inflammation, anxiety, insomnia, gut inflammation, and menstrual cramps, among other benefits.

Novelty and Inventive Step

The inventive concept's novelty lies in the expansion of the original technology to address previously unconsidered therapeutic applications, demonstrating a non-obvious and innovative approach to leveraging the core technology. The new claims introduce unexpected and valuable uses for the water-soluble, powdered cannabinoid and/or terpene extracts.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may involve different formulations, such as nasal sprays, suppositories, or injectables, to further expand the technology's reach. Variations may include the use of different cyclodextrins, emulsifiers, or additives to optimize the extracts' performance in specific applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential across multiple industries, including pharmaceuticals, veterinary care, cosmetics, and nutraceuticals. The target markets include patients suffering from skin conditions, pet owners seeking anxiety relief for their pets, individuals struggling with sleep disorders, and those experiencing gut inflammation or menstrual cramps. The market size is substantial, with potential revenue streams from licensing, partnerships, and product sales.

CPC Classifications

SectionClassGroup
A A61 A61K36/185
A A61 A61K9/107
A A61 A61K47/02
A A61 A61K47/36
A A61 A61K47/40
A A61 A61K47/44

Field of Art

Pharmaceutical and nutraceutical formulations, specifically cannabinoid extract preparation and delivery technologies, involving advanced drug delivery systems, emulsification techniques, and cyclodextrin complexation

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmaceutical sciences, chemistry, or chemical engineering, possessing expertise in drug formulation, extraction technologies, and knowledge of cannabinoid delivery mechanisms, familiar with cyclodextrin complexation and emulsification strategies

Obviousness Rationale

A PHOSITA would recognize that the source patent's water-soluble cannabinoid extraction method provides a foundational technology that can be readily adapted to diverse therapeutic applications. The core technological elements of cyclodextrin complexation, maltodextrin/acacia emulsification, and powdered extract preparation inherently suggest multiple potential medical uses. The PTD's variations represent predictable extensions of the original patent's technological framework, applying known formulation techniques to address specific therapeutic needs.

Obvious Combinations & Variations

Source Patent Element
Water-soluble, micronized cannabinoid extract complexed with cyclodextrin
PTD Variation
Topical cream formulation for dermatological inflammation treatment
Obviousness Reasoning
A PHOSITA would recognize that topical delivery is a standard, predictable method for applying pharmaceutical compounds, with cyclodextrin complexation enhancing water solubility and skin penetration
Source Patent Element
Powdered cannabis extract emulsified with maltodextrin and acacia
PTD Variation
Veterinary treat formulation for anxiety reduction
Obviousness Reasoning
Adapting pharmaceutical formulations across species is a routine practice, and the existing emulsification technique would be readily transferable to animal health applications
Source Patent Element
Cannabinoid extract with adjustable bulk density
PTD Variation
Capsule and tablet formulations for systemic therapeutic effects
Obviousness Reasoning
The source patent's emphasis on variable bulk density directly suggests adaptability to different oral dosage forms, making such variations an obvious design choice
Source Patent Element
Mesoporous silica loading technique for cannabinoid extracts
PTD Variation
Transdermal patch development for controlled release
Obviousness Reasoning
The original loading technique implies potential for controlled substance delivery, making transdermal patch development a predictable technological progression
Source Patent Element
Water-soluble cannabinoid extraction method
PTD Variation
Targeted treatment for specific conditions like menstrual cramps
Obviousness Reasoning
Identifying new therapeutic applications for existing pharmaceutical technologies is a standard scientific approach, particularly when the underlying formulation remains consistent
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be considered obvious to a person having ordinary skill in the art with reference to US Patent 11857589, as the claimed innovations represent predictable extensions of the foundational cannabinoid extraction and delivery technology, utilizing standard pharmaceutical formulation techniques to address specific therapeutic contexts without requiring inventive complexity beyond the capabilities of an ordinary practitioner in pharmaceutical sciences.

Original Patent Information

Patent NumberUS 11,857,589
TitleWater-soluble, powdered cannabinoid and/or terpene extract
Assignee(s)MEDPHARM HOLDINGS, LLC